168 related articles for article (PubMed ID: 21750715)
1. The inhibitor of growth protein 5 (ING5) depends on INCA1 as a co-factor for its antiproliferative effects.
Zhang F; Bäumer N; Rode M; Ji P; Zhang T; Berdel WE; Müller-Tidow C
PLoS One; 2011; 6(7):e21505. PubMed ID: 21750715
[TBL] [Abstract][Full Text] [Related]
2. Inhibitor of cyclin-dependent kinase (CDK) interacting with cyclin A1 (INCA1) regulates proliferation and is repressed by oncogenic signaling.
Bäumer N; Tickenbrock L; Tschanter P; Lohmeyer L; Diederichs S; Bäumer S; Skryabin BV; Zhang F; Agrawal-Singh S; Köhler G; Berdel WE; Serve H; Koschmieder S; Müller-Tidow C
J Biol Chem; 2011 Aug; 286(32):28210-22. PubMed ID: 21540187
[TBL] [Abstract][Full Text] [Related]
3. Identification of interaction partners and substrates of the cyclin A1-CDK2 complex.
Diederichs S; Bäumer N; Ji P; Metzelder SK; Idos GE; Cauvet T; Wang W; Möller M; Pierschalski S; Gromoll J; Schrader MG; Koeffler HP; Berdel WE; Serve H; Müller-Tidow C
J Biol Chem; 2004 Aug; 279(32):33727-41. PubMed ID: 15159402
[TBL] [Abstract][Full Text] [Related]
4. ING5 is phosphorylated by CDK2 and controls cell proliferation independently of p53.
Linzen U; Lilischkis R; Pandithage R; Schilling B; Ullius A; Lüscher-Firzlaff J; Kremmer E; Lüscher B; Vervoorts J
PLoS One; 2015; 10(4):e0123736. PubMed ID: 25860957
[TBL] [Abstract][Full Text] [Related]
5. Zinc finger protein HZF1 promotes K562 cell proliferation by interacting with and inhibiting INCA1.
Li XB; Chen J; Deng MJ; Wang F; Du ZW; Zhang JW
Mol Med Rep; 2011; 4(6):1131-7. PubMed ID: 21874239
[TBL] [Abstract][Full Text] [Related]
6. ING5 suppresses proliferation, apoptosis, migration and invasion, and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression.
Gou WF; Shen DF; Yang XF; Zhao S; Liu YP; Sun HZ; Su RJ; Luo JS; Zheng HC
Oncotarget; 2015 Aug; 6(23):19552-79. PubMed ID: 25980581
[TBL] [Abstract][Full Text] [Related]
7. ING5 inhibits cancer aggressiveness via preventing EMT and is a potential prognostic biomarker for lung cancer.
Zhang F; Zhang X; Meng J; Zhao Y; Liu X; Liu Y; Wang Y; Li Y; Sun Y; Wang Z; Mei Q; Zhang T
Oncotarget; 2015 Jun; 6(18):16239-52. PubMed ID: 25938545
[TBL] [Abstract][Full Text] [Related]
8. ING5 Inhibits Migration and Invasion of Esophageal Cancer Cells by Downregulating the IL-6/CXCL12 Signaling Pathway.
Wang Y; Tan J; Li J; Chen H; Wang W
Technol Cancer Res Treat; 2021; 20():15330338211039940. PubMed ID: 34520285
[TBL] [Abstract][Full Text] [Related]
9. ING5 inhibits lung cancer invasion and epithelial-mesenchymal transition by inhibiting the WNT/β-catenin pathway.
Liu XL; Meng J; Zhang XT; Liang XH; Zhang F; Zhao GR; Zhang T
Thorac Cancer; 2019 Apr; 10(4):848-855. PubMed ID: 30810286
[TBL] [Abstract][Full Text] [Related]
10. ING5 is a Tip60 cofactor that acetylates p53 in response to DNA damage.
Liu N; Wang J; Wang J; Wang R; Liu Z; Yu Y; Lu H
Cancer Res; 2013 Jun; 73(12):3749-60. PubMed ID: 23576563
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-193 pro-proliferation effects for bone mesenchymal stem cells after low-level laser irradiation treatment through inhibitor of growth family, member 5.
Wang J; Huang W; Wu Y; Hou J; Nie Y; Gu H; Li J; Hu S; Zhang H
Stem Cells Dev; 2012 Sep; 21(13):2508-19. PubMed ID: 22384930
[TBL] [Abstract][Full Text] [Related]
12. ING5 suppresses breast cancer progression and is regulated by miR-24.
Cui S; Liao X; Ye C; Yin X; Liu M; Hong Y; Yu M; Liu Y; Liang H; Zhang CY; Chen X
Mol Cancer; 2017 May; 16(1):89. PubMed ID: 28490335
[TBL] [Abstract][Full Text] [Related]
13. Maintenance of leukemia-initiating cells is regulated by the CDK inhibitor Inca1.
Bäumer N; Bäumer S; Berkenfeld F; Stehling M; Köhler G; Berdel WE; Müller-Tidow C; Tschanter P
PLoS One; 2014; 9(12):e115578. PubMed ID: 25525809
[TBL] [Abstract][Full Text] [Related]
14. ING5-mediated antineuroblastoma effects of suberoylanilide hydroxamic acid.
Wu JC; Jiang HM; Yang XH; Zheng HC
Cancer Med; 2018 Sep; 7(9):4554-4569. PubMed ID: 30091530
[TBL] [Abstract][Full Text] [Related]
15. ING5 inhibits cell proliferation and invasion in esophageal squamous cell carcinoma through regulation of the Akt/NF-κB/MMP-9 signaling pathway.
Zhang GJ; Zhao J; Jiang ML; Zhang LC
Biochem Biophys Res Commun; 2018 Feb; 496(2):387-393. PubMed ID: 29326045
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of ING5 inhibits HGF-induced proliferation, invasion and EMT in thyroid cancer cells via regulation of the c-Met/PI3K/Akt signaling pathway.
Gao W; Han J
Biomed Pharmacother; 2018 Feb; 98():265-270. PubMed ID: 29272787
[TBL] [Abstract][Full Text] [Related]
17. The down-regulated ING5 expression in lung cancer: a potential target of gene therapy.
Zhao S; Yang XF; Shen DF; Gao Y; Shi S; Wu JC; Liu HX; Sun HZ; Su RJ; Zheng HC
Oncotarget; 2016 Aug; 7(34):54596-54615. PubMed ID: 27409347
[TBL] [Abstract][Full Text] [Related]
18. Decreased growth of Vhl-/- fibrosarcomas is associated with elevated levels of cyclin kinase inhibitors p21 and p27.
Mack FA; Patel JH; Biju MP; Haase VH; Simon MC
Mol Cell Biol; 2005 Jun; 25(11):4565-78. PubMed ID: 15899860
[TBL] [Abstract][Full Text] [Related]
19. AP4 is required for mitogen- and c-MYC-induced cell cycle progression.
Jackstadt R; Hermeking H
Oncotarget; 2014 Sep; 5(17):7316-27. PubMed ID: 25261373
[TBL] [Abstract][Full Text] [Related]
20. Truncation of inhibitor of growth family protein 5 effectively induces senescence, but not apoptosis in human tongue squamous cell carcinoma cell line.
Qi L; Zhang Y
Tumour Biol; 2014 Apr; 35(4):3139-44. PubMed ID: 24254310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
